Your browser doesn't support javascript.
loading
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE.
Santini, Daniele; Cinieri, Saverio; Gasparro, Donatello; Bordonaro, Roberto; Guglielmini, Pamela Francesca; Chiuri, Vincenzo Emanuele; D'Angelillo, Rolando M; Ceresoli, Giovanni Luca; Fagnani, Daniele; Acquati, Mirko; Mencoboni, Manlio; Lanzetta, Gaetano; Sartori, Donata; Carlini, Paolo; Panebianco, Fabiana; Beccaglia, Patrizia; Procopio, Giuseppe.
Afiliación
  • Santini D; Department of Oncology, Campus Bio-Medico University, Rome, Italy.
  • Cinieri S; Medical Oncology Unit, Antonio Perrino Hospital, Brindisi, Italy.
  • Gasparro D; Medical Oncology Unit, Department of General & Specialistic Medicine, University Hospital of Parma, Italy.
  • Bordonaro R; MD - ARNAS Garibaldi, Catania, Italy.
  • Guglielmini PF; Medical Oncology Department, Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Chiuri VE; Medical Oncology Department, Ospedale Vito Fazzi, Lecce, Italy.
  • D'Angelillo RM; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Ceresoli GL; Department of Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Fagnani D; Medical Oncology Division - ASST, Vimercate, Italy.
  • Acquati M; Unit of Medical Oncology, Azienda Ospedaliera San Gerardo, Monza, Italy.
  • Mencoboni M; Oncology Unit, Villa Scassi Hospital, 16149 Genova, Italy.
  • Lanzetta G; Department Oncology and Palliative Care, INI Grottaferrata, Rome, Italy.
  • Sartori D; Oncology Unit, AULSS 3, Mirano, Italy.
  • Carlini P; Division of Medical Oncology 1, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Panebianco F; Medical Affairs Department, Oncology, Janssen-Cilag SpA, Cologno Monzese, Milan, Italy.
  • Beccaglia P; Medical Affairs Department, Oncology, Janssen-Cilag SpA, Cologno Monzese, Milan, Italy.
  • Procopio G; Department of Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy.
J Bone Oncol ; 26: 100341, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33425672

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Bone Oncol Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Bone Oncol Año: 2021 Tipo del documento: Article País de afiliación: Italia